Concepedia

The Receptor Binding Profile of the New Antihypertensive Agent Nebivolol and its Stereoisomers Compared with Various β-Adrenergic Blockers

J.E. Leysen, Petrus J. Pauwels, W Gommeren, Guy Van Lommen, Patricia A. Janssen

Clinical Drug Investigation · 1991 · 38 citations · 2 references

Open access

Concepts

MedicineMedicinal ChemistryPharmacologyCardiovascular PharmacotherapyPharmacodynamicsBlood Pressure ControlBlood Pressure ManagementCardiovascular PharmacologyDrug-receptor InteractionsReceptor BindingReceptor PharmacologyAntihypertensive Drug TherapyAntihypertensive PharmacologyAntihypertensive TreatmentBeta-adrenergic Receptor PharmacodynamicsBlood Pressure PharmacodynamicsReceptor Binding OptimizationReceptor Binding Specificity

References

2

Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist

A. Van de Water, Wim Janssens, J. Van Neuten et al. · Journal of Cardiovascular Pharmacology · 1988 · 199 citations

Medicine, Cardiology, Pharmacology +14

Haemodynamic effects in man during exercise of a single oral dose of narbivolol (R 67555), a new beta‐1‐adrenoceptor blocking agent: A comparative study with atenolol, pindolol, and propranolol

J. De Crée, H. Geukens, J. Leempoels et al. · Drug Development Research · 1986 · 68 citations

Medicine, Pharmacology, Physiology +17